Cytowanie według stylu APA (wyd. 7)

Folegatti, P., Bittaye, M., Flaxman, A., Ramos Lopez, F., Bellamy, D., Mair, C., . . . al, E. (2020). Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: A dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial. Elsevier.

Cytowanie według stylu Chicago (wyd. 17)

Folegatti, PM, et al. Safety and Immunogenicity of a Candidate Middle East Respiratory Syndrome Coronavirus Viral-vectored Vaccine: A Dose-escalation, Open-label, Non-randomised, Uncontrolled, Phase 1 Trial. Elsevier, 2020.

Cytowanie według stylu MLA (wyd. 9)

Folegatti, PM, et al. Safety and Immunogenicity of a Candidate Middle East Respiratory Syndrome Coronavirus Viral-vectored Vaccine: A Dose-escalation, Open-label, Non-randomised, Uncontrolled, Phase 1 Trial. Elsevier, 2020.